Discover how BioDuro’ s innovative bioanalytical technology overcomes critical challenges in quantifying siRNA therapeutics. This case study highlights our breakthrough approach for precise, sensitive quantification of Givosiran—an FDA-approved siRNA drug—accelerating PK and tissue distribution studies in preclinical development.

Key Highlights

• Novel Quantification Method: Leverages proprietary technology for enhanced sensitivity and selectivity.
• Streamlined Workflow: Reduces analysis time by 40% and improves sensitivity 5x versus traditional methods.
• Cross-Tissue Application: Successfully quantified siRNA in plasma, liver, and kidney samples from mouse PK studies.
• Efficiency-Driven: Simplifies sample processing and supports high-throughput workflows for faster drug discovery.

Download the full case study to transform your development strategy with proven bioanalytical innovation.